Efficient pharmaceutical inventory management is crucial for healthcare organizations to ensure patient satisfaction, maintain financial stability, and mitigate supply chain risks. Moving forward, drug manufacturers must adapt their inventory management processes to accommodate the Drug Supply Chain Security Act (DSCSA) serialization requirements, balancing the challenges with the potential benefits of improved patient safety, supply chain efficiency, and regulatory compliance.

As the landscape of the pharmaceutical industry continues to evolve, the need for more improved Channel data insights becomes more apparent. Manufacturers require Channel and Gross-to-Net operations to be aligned more than ever and, as a result, Channel data monitoring must evolve as well. IntegriChain has developed Inventory Roll Forward monitoring to meet this need. Pharma inventory roll forwards help to understand the accuracy of inventory movement reported by trade partners so that stakeholders can take more timely and more informed action. Manufacturers can expect to obtain the following benefits by routine, monthly monitoring of inventory roll forwards. This report will become an essential tool for effective inventory management in the pharma industry, providing insights into product availability, financial accuracy, and supply chain performance.

Ensuring Product Availability

Anticipating and meeting product demand is crucial for ensuring smooth operations and maintaining customer trust. By leveraging pharma inventory roll forward monitoring, manufacturers can track product movement and proactively prevent stockouts.

Accurate demand forecasting, efficient ordering processes, and strong supplier relationships all contribute to ensuring products remain available when needed. Utilizing inventory roll forward tools and real-time data insights helps manufacturers align inventory levels with market demand, improving pharmaceutical inventory management and reducing supply chain disruptions.

Pipeline Accuracy

Determining faster and more accurate accruals is essential for financial stability and operational efficiency. Inventory roll forward monitoring allows pharma manufacturers to validate trade partner-reported stock movements, ensuring that financial projections align with actual sales.

By reducing true-ups, businesses can minimize discrepancies between estimated and actual financial outcomes. Regularly analyzing inventory roll forward reports helps companies maintain accurate pipeline forecasting and improve inventory management in the pharma industry.

Managing Supply Chain Risks

Identify potential supply chain disruptions early on and take proactive measures to mitigate their impact. Inventory management helps companies build resilience and minimize risks associated with supply chain uncertainties.

To better assist pharma manufacturers in the Inventory Roll Forward for individual trade partners and brands, our tool includes several layers of analysis across critical datasets.In addition to the Inventory Roll Forward tool, a concise dashboard helps users to validate the sales alignment between the 852 data and 867 data. Users also have the ability to view a Monthly Sales Reconciliation breakdown, which analyzes the EXF quantity reported against key 852 metrics.

We recommend users run this report on a quarterly or monthly basis to assess whether the inventory roll forward is within an acceptable range. If the inventory roll forward, sales alignment, or sales reconciliation metrics raise any additional questions for the user, this analytics tool allows users to dive into the data at a daily level to triage the root cause of the issue.

Gross to Net Accounting Challenges in Pharma

The pharma industry faces significant gross-to-net accounting challenges, particularly when launching new products. Managing rebates, chargebacks, and discounts requires precise financial forecasting to ensure compliance and avoid revenue misstatements.

Incorporating inventory roll forward monitoring into GTN processes helps manufacturers validate trade partner-reported inventory, improving alignment between financial estimates and actual sales. Leveraging tools enhances financial transparency, reduces revenue fluctuations, and strengthens pharma inventory management strategies.

Pharmaceutical Inventory Management

If you would like to learn more about Inventory Roll Forwards and how they can lead to more accurate and timely data quality and monitoring, or are looking to bolster your Gross-to-Net solutions, please contact your Account Manager or Customer Engagement Representative to discuss how IntegriChain can help support you.

GET INVENTORY ROLL FORWARD MONITORING

About the Author

Mathew Gravesande

Mathew Gravesande

Director of Customer Engagement and Support

As the Director of Customer Engagement and Support, Matt is focused on helping clients utilize and leverage the data available to best meet their business needs. He has over five years of experience in his current role working with customers of various sizes and supporting a variety of tasks ranging from product additions to full scale implementation support. Prior to IntegriChain, Matt spent 5 years as a management consultant for Deloitte working with large health care systems.